125 related articles for article (PubMed ID: 34089986)
41. Development and validation of a 96-well cellular assay for the discovery of ALDH1A1 inhibitors.
Ming W; Ma W; Chen LH; Volk C; Michael MD; Xu Y; Zhang F; Wang X
Assay Drug Dev Technol; 2013 Jul; 11(6):388-95. PubMed ID: 23957476
[TBL] [Abstract][Full Text] [Related]
42. Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2.
Wang B; Buchman CD; Li L; Hurley TD; Meroueh SO
J Chem Inf Model; 2014 Jul; 54(7):2105-16. PubMed ID: 24856086
[TBL] [Abstract][Full Text] [Related]
43. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
[TBL] [Abstract][Full Text] [Related]
44. Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay.
Uba AI; Yelekçi K
J Biomol Struct Dyn; 2018 Sep; 36(12):3231-3245. PubMed ID: 28938863
[TBL] [Abstract][Full Text] [Related]
45. PRMT3 interacts with ALDH1A1 and regulates gene-expression by inhibiting retinoic acid signaling.
Verma M; Khan MIK; Kadumuri RV; Chakrapani B; Awasthi S; Mahesh A; Govindaraju G; Chavali PL; Rajavelu A; Chavali S; Dhayalan A
Commun Biol; 2021 Jan; 4(1):109. PubMed ID: 33495566
[TBL] [Abstract][Full Text] [Related]
46. Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice.
Lassen N; Bateman JB; Estey T; Kuszak JR; Nees DW; Piatigorsky J; Duester G; Day BJ; Huang J; Hines LM; Vasiliou V
J Biol Chem; 2007 Aug; 282(35):25668-76. PubMed ID: 17567582
[TBL] [Abstract][Full Text] [Related]
47. Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity.
Liang D; Fan Y; Yang Z; Zhang Z; Liu M; Liu L; Jiang C
Eur J Med Chem; 2020 Feb; 187():111923. PubMed ID: 31816557
[TBL] [Abstract][Full Text] [Related]
48. Identification of approved drugs with ALDH1A1 inhibitory potential aimed at enhancing chemotherapy sensitivity in cancer cells: an in-silico drug repurposing approach.
Paul SK; Guendouzi A; Banerjee A; Guendouzi A; Haldar R
J Biomol Struct Dyn; 2024 Jan; ():1-15. PubMed ID: 38189344
[TBL] [Abstract][Full Text] [Related]
49. Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes.
Takahashi C; Chtcherbinine M; Huddle BC; Wilson MW; Emmel T; Hohlman RM; McGonigal S; Buckanovich RJ; Larsen SD; Hurley TD
Chem Biol Interact; 2024 Mar; 391():110910. PubMed ID: 38364885
[TBL] [Abstract][Full Text] [Related]
50. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.
Visus C; Ito D; Amoscato A; Maciejewska-Franczak M; Abdelsalem A; Dhir R; Shin DM; Donnenberg VS; Whiteside TL; DeLeo AB
Cancer Res; 2007 Nov; 67(21):10538-45. PubMed ID: 17974998
[TBL] [Abstract][Full Text] [Related]
51. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M
Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662
[TBL] [Abstract][Full Text] [Related]
52. Uncompetitive inhibition of Xenopus laevis aldehyde dehydrogenase 1A1 by divalent cations.
Rahman FB; Yamauchi K
Zoolog Sci; 2006 Mar; 23(3):239-44. PubMed ID: 16603817
[TBL] [Abstract][Full Text] [Related]
53. Aldehyde dehydrogenases and cancer stem cells.
Xu X; Chai S; Wang P; Zhang C; Yang Y; Yang Y; Wang K
Cancer Lett; 2015 Dec; 369(1):50-7. PubMed ID: 26319899
[TBL] [Abstract][Full Text] [Related]
54. Aldehyde dehydrogenase 1A1 in stem cells and cancer.
Tomita H; Tanaka K; Tanaka T; Hara A
Oncotarget; 2016 Mar; 7(10):11018-32. PubMed ID: 26783961
[TBL] [Abstract][Full Text] [Related]
55. BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
Yokoyama Y; Zhu H; Lee JH; Kossenkov AV; Wu SY; Wickramasinghe JM; Yin X; Palozola KC; Gardini A; Showe LC; Zaret KS; Liu Q; Speicher D; Conejo-Garcia JR; Bradner JE; Zhang Z; Sood AK; Ordog T; Bitler BG; Zhang R
Cancer Res; 2016 Nov; 76(21):6320-6330. PubMed ID: 27803105
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of human alcohol and aldehyde dehydrogenases by acetaminophen: Assessment of the effects on first-pass metabolism of ethanol.
Lee YP; Liao JT; Cheng YW; Wu TL; Lee SL; Liu JK; Yin SJ
Alcohol; 2013 Nov; 47(7):559-65. PubMed ID: 24169088
[TBL] [Abstract][Full Text] [Related]
57. Opossum aldehyde dehydrogenases: evidence for four ALDH1A1-like genes on chromosome 6 and ALDH1A2 and ALDH1A3 genes on chromosome 1.
Holmes RS
Biochem Genet; 2009 Oct; 47(9-10):609-24. PubMed ID: 19455414
[TBL] [Abstract][Full Text] [Related]
58. The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
Althobiti M; El Ansari R; Aleskandarany M; Joseph C; Toss MS; Green AR; Rakha EA
Histopathology; 2020 Sep; 77(3):437-448. PubMed ID: 32369651
[TBL] [Abstract][Full Text] [Related]
59. Multiple Machine Learning Based-Chemoinformatics Models for Identification of Histone Acetyl Transferase Inhibitors.
Krishna S; Kumar S; Singh DK; Lakra AD; Banerjee D; Siddiqi MI
Mol Inform; 2018 Aug; 37(8):e1700150. PubMed ID: 29683269
[TBL] [Abstract][Full Text] [Related]
60. Structural, Biochemical, and Computational Studies Reveal the Mechanism of Selective Aldehyde Dehydrogenase 1A1 Inhibition by Cytotoxic Duocarmycin Analogues.
Koch MF; Harteis S; Blank ID; Pestel G; Tietze LF; Ochsenfeld C; Schneider S; Sieber SA
Angew Chem Int Ed Engl; 2015 Nov; 54(46):13550-4. PubMed ID: 26373694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
